Treon SP - Search Results

1

Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenström's macroglobulinemia.

Jiménez C, Xu L, Tsakmaklis N, Demos MG, Kofides A, Chan GG, Guerrera ML, Chen JG, Liu X, Munshi M, Patterson CJ, Yang G, Castillo JJ, Treon SP, Hunter ZR. Jiménez C, et al. Among authors: treon sp. Blood Adv. 2020 Sep 22;4(18):4550-4553. doi: 10.1182/bloodadvances.2020001775. Blood Adv. 2020. PMID: 32956451 Free PMC article.

2

Defining Waldenstrom's macroglobulinemia.

Treon SP, Dimopoulos M, Kyle RA. Treon SP, et al. Semin Oncol. 2003 Apr;30(2):107-9. doi: 10.1053/sonc.2003.50081. Semin Oncol. 2003. PMID: 12720117 No abstract available.

3

Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.

Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Kriangkum J, et al. Among authors: treon sp. Blood. 2004 Oct 1;104(7):2134-42. doi: 10.1182/blood-2003-11-4024. Epub 2004 Feb 5. Blood. 2004. PMID: 14764523 Free article.

4

Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia.

Treon SP, Branagan AR, Hunter Z, Santos D, Tournhilac O, Anderson KC. Treon SP, et al. Ann Oncol. 2004 Oct;15(10):1481-3. doi: 10.1093/annonc/mdh403. Ann Oncol. 2004. PMID: 15367407 Free article. Clinical Trial.

5

Extended rituximab therapy in Waldenström's macroglobulinemia.

Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR; Waldenström's Macroglobulinemia Clinical Trials Group. Treon SP, et al. Ann Oncol. 2005 Jan;16(1):132-8. doi: 10.1093/annonc/mdi022. Ann Oncol. 2005. PMID: 15598950 Free article. Clinical Trial.

6

Clinical responses to sildenafil in Waldenstrom's macroglobulinemia.

Treon SP, Tournilhac O, Branagan AR, Hunter Z, Xu L, Hatjiharissi E, Santos DD. Treon SP, et al. Clin Lymphoma. 2004 Dec;5(3):205-7. doi: 10.3816/clm.2004.n.029. Clin Lymphoma. 2004. PMID: 15636699

7

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA. Treon SP, et al. J Clin Oncol. 2005 Jan 20;23(3):474-81. doi: 10.1200/JCO.2005.06.059. J Clin Oncol. 2005. PMID: 15659493 Clinical Trial.

8

Report of the Third International Workshop on Waldenstrom's macroglobulinemia.

Treon SP, Morel P, Leblond V, Fermand JP. Treon SP, et al. Clin Lymphoma. 2005 Mar;5(4):215-6. doi: 10.3816/clm.2005.n.001. Clin Lymphoma. 2005. PMID: 15794850 No abstract available.

9

CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.

Hunter ZR, Branagan AR, Manning R, Patterson CJ, Santos DD, Tournilhac O, Dorfman DM, Treon SP. Hunter ZR, et al. Among authors: treon sp. Clin Lymphoma. 2005 Mar;5(4):246-9. doi: 10.3816/clm.2005.n.008. Clin Lymphoma. 2005. PMID: 15794857

10

CHOP plus rituximab therapy in Waldenstrom's macroglobulinemia.

Treon SP, Hunter Z, Barnagan AR. Treon SP, et al. Clin Lymphoma. 2005 Mar;5(4):273-7. doi: 10.3816/clm.2005.n.015. Clin Lymphoma. 2005. PMID: 15794864 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters